OPKO Health (OPK): Shares To Trade Lower On Reimbursement Concerns - Jefferies

October 7, 2016 8:15 AM EDT
Get Alerts OPK Hot Sheet
Price: $8.98 +0.56%

Rating Summary:
    5 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 22 | New: 54
Trade OPK Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Jefferies analyst, Brandon Couillard, reiterated his Hold rating on shares of Opko Health (NASDAQ: OPK) along with a price target of $10. Palmetto posted a final LCD for OPK's 4Kscore prostate cancer test that argued against Medicare coverage.

The analyst believes that Palmetto's no-coverage decision is a major setback for 4K which had been perceived as a key near term growth driver. Going one step further, the analyst thinks that Palmetto's clout in the Dx space will cause OPK's local MAC (Novitas) to follow suit.

Without Medicare, 4K's commercial pathway from here is unclear.

For an analyst ratings summary and ratings history on Opko Health click here. For more ratings news on Opko Health click here.

Shares of Opko Health closed at $10.43 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Jefferies & Co

Add Your Comment